CombineHealth vs Trase
Two RCM Automation Platforms vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| CombineHealth | Trase | |
|---|---|---|
| Pricing model | Per-transaction / per-chart · Priced per chart or claim worked | Enterprise contract (custom) · No upfront fee, billed on efficiency gains |
| Speed to go live | Sidecar agents on existing EHR, weeks | Prebuilt agent library deploys in weeks |
| Automation model | Autonomous agents · Named agents with human escalation | Autonomous agents · Governed agent OS for regulated work |
| Built for | Mid-size groups, Billing companies | Enterprise systems |
| Security posture | SOC 2 Type II, HIPAA | SOC 2 Type I, HIPAA |
| Company maturity | 4 yrs (est. 2022) | Not disclosed |
| Financial backing | Pre-seed (Y Combinator W23) | $117.5M ($10.5M pre-seed plus $107M seed) · Seed |
| Named customers | 5 named | 2 named |
| Published results | Specific numbers public | Specific numbers public |
| Documented integrations | 3 listed | None documented |
| Third-party validation | None found | None found |
Bottom line
- Pick CombineHealth if you want an early-stage, aggressively priced AI agent workforce across coding, billing, and denials and can accept startup vendor risk.
- Pick Trase if you are an academic or large health system that wants governed AI agents across back-office workflows and prefers paying from measured efficiency gains.
CombineHealth
Named AI agents that work the revenue cycle end to end
- Founded
- 2022
- HQ
- San Francisco, CA
- Stage
- Pre-seed (Y Combinator W23)
- Raised
- $500K
What it does
- Amy codes encounters with rationale in 2-4 minutes
- Mark preps claim-ready charges and posts payments
- Adam works denials, payer portals, and IVR calls
- Rachel drafts and files appeals
- Taylor surfaces revenue cycle analytics and leakage
- Human-in-the-loop escalation with explainable decisions
Where it's strong
- Covers front, mid, and back office with one agent framework instead of point tools.
- Publishes concrete accuracy claims (97% coding accuracy, 20% denial reduction on 10,000+ claims).
- Small YC-backed team moves fast and prices aggressively against legacy RCM vendors.
What buyers should weigh
- Only $500K disclosed funding and a small team, so vendor viability is a real diligence item.
- Customer list skews to mid-size groups and ER networks, not large health systems.
- Agent autonomy claims need validation in your specialty and payer mix before scaling.
Named customers
Union Health · McFarland Clinic · SignatureCare ER · Brault · Medcor
Integrations
Trase
Governed AI agents for healthcare back-office work
- Founded
- n/a
- HQ
- McLean, VA
- Stage
- Seed
- Raised
- $117.5M ($10.5M pre-seed plus $107M seed)
What it does
- AI agents for inbound fax triage and routing
- Patient access workflow automation
- Revenue cycle task automation
- HIPAA and SOC 2 compliant agent platform
- Governance and oversight controls for agent actions
Where it's strong
- Live health system deployment at Duke, where fax triage ran 7.1 times faster than manual processing and saved about 1,395 staff hours a month.
- The $107M seed led by ARCH Venture Partners gives it unusual capital depth for a company at this stage.
- Pricing tied to measured efficiency gains lowers the risk of paying for software that does not perform.
What buyers should weigh
- The company only came out of stealth in November 2025, so the reference base beyond Duke Health is thin.
- The platform spans healthcare, defense, and other regulated industries, so healthcare-specific product depth may lag single-focus rivals.
- Published results center on fax triage; patient access and RCM claims have less public evidence.
Named customers
Duke Health · U.S. Navy
Compare against the rest of RCM Automation Platforms
Deciding between these two?
First Pass tracks RCM Automation Platforms every week: funding, launches, and what changed since this page was written.